0001415889-24-019471.txt : 20240710 0001415889-24-019471.hdr.sgml : 20240710 20240710173352 ACCESSION NUMBER: 0001415889-24-019471 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240708 FILED AS OF DATE: 20240710 DATE AS OF CHANGE: 20240710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tipirneni Praveen P. CENTRAL INDEX KEY: 0001779978 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38940 FILM NUMBER: 241110661 MAIL ADDRESS: STREET 1: C/O MORPHIC HOLDING, INC., STREET 2: 35 GATEHOUSE DRIVE, A2 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Morphic Holding, Inc. CENTRAL INDEX KEY: 0001679363 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473878772 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 GATEHOUSE DRIVE A2 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 996-0955 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DRIVE A2 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Morphic Holding, LLC DATE OF NAME CHANGE: 20160712 4 1 form4-07102024_090748.xml X0508 4 2024-07-08 0001679363 Morphic Holding, Inc. MORF 0001779978 Tipirneni Praveen P. C/O MORPHIC HOLDING, INC. 35 GATEHOUSE DRIVE, A2 WALTHAM MA 02451 true true false false President and CEO 1 Common Stock 2024-07-08 4 M 0 21582 4.3151 A 64042 D Common Stock 2024-07-08 4 S 0 21582 55.7907 D 42460 D Employee Stock Option (right to buy) 4.3151 2024-07-08 4 M 0 21582 0 D 2028-12-14 Common Stock 21582 339561 D Includes 447 shares of Common Stock acquired under the issuer's employee stock purchase plan on February 29, 2024. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2023. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.79 to $55.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option is fully vested. /s/ Robert Farrell for Praveen P. Tipirneni 2024-07-10